Zoledronic Acid Effective as Rescue Treatment for Ankylosing Spondylitis Refractory to TNF Inhibition

Abstract

View all access options for this article.

Bijlsma

Silva

Hachula

Doherty

Cope

Lioté

. EULAR Textbook on Rheumatic Disease. London, UK: BMJ Publishing Group; 2012.

Kiltz

Heldmann

Baraliakos

Braun

. Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives? Curr Opin Rheumatol. 2012;24:252-260.

Haibel

Brandt

Rudwaleit

Soerensen

Sieper

Braun

. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology (Oxford). 2003;42:1018-1020.

Grover

Shankar

Aneja

Marwaha

Gupta

Kumar

. Treatment of ankylosing spondylitis with pamidronate: an open label study. Ann Rheum Dis. 2006;65:688-689.

Viapiana

Gatti

Idolazzi

. Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology (Oxford). 2014;53:90-94.

Clunie

Ginawi

O’Conner

. An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Ann Rheum Dis. 2014;73:1273-1274.